Andrea Agathoklis Murino

Andrea Agathoklis Murino

Partner Chair, Washington D.C.
Andrea Agathoklis Murino

Andrea Agathoklis Murino is a Chambers-ranked partner in and co-chair of Goodwin’s Antitrust & Competition Law practice, chair of its Washington D.C. office, and a member of the firm’s Executive Committee. Ms. Murino’s unique combination of private and public sector experience allow her to provide practical, bespoke, and efficient pathways to achieving her clients’ business objectives. Her primary focus is securing clearances for proposed transactions from the Antitrust Division of the U.S. Department of Justice, the U.S. Federal Trade Commission, state attorneys general, and international competition law enforcement agencies. In the past year alone, she has successfully represented more than 100 clients through all manner of transaction-related investigations, including several high-profile Second Requests and dozens of intensive public and non-public investigations. Ms. Murino also has significant merger litigation experience, having served as senior member of a trial team that defended a rare consummated merger challenge in federal court. Furthermore, she regularly advises on numerous other competition issues, including dominant firm conduct, competitor collaborations, and distribution practices. Ms. Murino’s practice also includes representing clients on consumer protection matters before the FTC and state attorneys general, including claims of false advertising and deceptive marketing practices. Among her clients are companies in the healthcare, pharmaceuticals, technology, financial services, telecommunications, medical devices, consumer products, hospitality, real estate, and retail industries.

Ms. Murino served the highest decision-makers at both federal antitrust enforcement agencies. She was an attorney advisor to former FTC Chairman and Commissioner William Kovacic where she offered advice on a diverse array of competition and consumer protection matters. She then served as a counsel to two Assistant Attorneys General for Antitrust at the Department of Justice where she advised the Assistant Attorney General and the Deputy Assistant Attorneys General on criminal and civil enforcement matters. She joined Goodwin after having been a partner with Wilson Sonsini Goodrich & Rosati and spent the earlier part of her career as an associate with Freshfields Bruckhaus Deringer.

Ms. Murino is recognized in the Washington, DC Antitrust & Competition category in Chambers USA: America’s Leading Lawyers for Business, where clients praised her for being “relentless in seeking out all possible angles.” She was named to Who's Who Legal Competition: Future Leaders 2019 and 2018 where her “pragmatic approach” and “strong expertise and deep business knowledge” was cited. Ms. Murino was also named to The National Law Journal’s 2018 M&A and Antitrust Trailblazers list, an award that recognizes lawyers who continue to make their mark in various aspects of deal making and strategic planning. She has been named to Global Competition Review’s Women in Antitrust list, which recognizes remarkable women at the helm of law firms' competition practices, and to the 2016 Global Competition Review 40 Under 40 list. She has also been recognized as a “Top Rated Antitrust Attorney” by Super Lawyers.

A frequent speaker, Ms. Murino spoke at the FTC’s Hearings on Competition and Consumer Protection in the 21st Century addressing multi-sided platforms, labor markets, and potential competition. She has been a member of Law360’s Competition Law Editorial Advisory Board since 2016 and now serves on the MLex Advisory Board, where she consults and advises on significant developments impacting antitrust and competition law. Ms. Murino also contributes to the “Antitrust Practice Advisor” for LexisNexis, which offers a collection of practical guidance written by attorneys for their practice areas.

Areas of Practice
Domaines D’Expertise





Since January 1, 2017, Ms. Murino and her team have represented clients successfully in the following in-depth investigations (Second Requests) before the FTC and DOJ:

  • Beth Israel Deaconess Medical Center, Lahey Health System, New England Baptist Hospital, Mount Auburn Hospital, and Seacoast Regional Health System in their $5+ billion merger to create Beth Israel Lahey Health, the second largest healthcare system in the Eastern Massachusetts area. Approvals were required from both the FTC and multiple state-level agencies, including the Office of the Attorney General of Massachusetts. The Boston Globe described the combination as “the most significant health care deal in Massachusetts” in decades.
  • Rainmaker in its $300 million sale of its LRO software and related assets to RealPage. After concluding compliance with a Second Request process, this transaction was cleared by the DOJ without condition.
  • Concert Pharmaceuticals in the $250 million sale of its cystic fibrosis drug to Vertex Pharmaceuticals. The FTC issued a Second Request in this transaction that combined two makers of a certain cystic fibrosis treatments. By using novel strategies to minimize the scope of the Second Request and therefore speed the FTC review process, we achieved unconditional clearance in unprecedented time of less than 6 weeks.
  • SGL Group of Germany in the $400 million sale of its worldwide graphite electrode business to Showa Denko KK of Japan. Following compliance with a Second Request from the DOJ, this transaction was cleared.

Ms. Murino’s work in assuring antitrust clearance in publicly announced transactions which were required to be reported under the HSR Act include:

  • Truck Hero International, a leading automotive accessories provider, in its acquisition of Lund International, another leading automotive accessories provider
  • Brammer Bio in Its $1.7 Billion Sale to Thermo Fisher Scientific
  • Ipsen in its $1.3 billion acquisition of Clementia Pharmaceuticals
  • Twilio in its $3b acquisition of SendGrid
  • TurnItIn in its $1.75b sale to Advance Publications
  • The Independent Directors of Sprint Corporation in their $59 billion merger with T-Mobile USA
  • PillPack, Inc. in its $1 billion acquisition by Amazon
  • Control4 in its $680 million sale to SnapAV
  • Qualtrics in its $8 billion acquisition by SAP SE
  • Marc and Lynne Benioff in their acquisition of TIME Media from Meredith Corporation
  • Thoma Bravo, LLC in its acquisition of motus, LLC and Runzheimer International LLC
  • hyperWALLET Systems, Inc. in its $400 million acquisition by PayPal in the United States
  • Teva Pharmaceuticals in its $2 billion sale of its women’s health business
  • Amplify Snack Brands, Inc. in its sale to The Hershey Company for $1.6 billion. 
  • Kind, Inc. (makers of Kind bars) in its $4 billion investment from Mars, Inc.
  • Eventbrite's in its $200 million purchase of Ticketfly
  • Lennar Corporation in its $9.3 billion acquisition of CalAtlantic Group, creating the United States’ largest homebuilder 
  • Onyx Pharmaceuticals in its $10.4 billion acquisition by Amgen
  • Wirtgen Group in its $5 billion sale to John Deere & Company
  • Parexel in its $5 billion sale to Pamploma Capital
  •, Inc. in its $1.5 billion acquisition by LinkedIn Corporation
  • Partners Group in its $1.5 billion acquisition of Knowledge Universe Education
  • Xoom Corporation in its $890 million acquisition by eBay

Other notable work for clients outside the HSR context includes:

  • Providing antitrust counsel and guidance to multiple healthcare providers and healthcare systems across the United States seeking to expand their networks in proceedings before the federal antitrust authorities, their relevant state regulatory bodies, and state attorneys general.
  • Successfully representing multiple third parties in the federal district court proceedings related to the FTC and DOJ merger challenges
  • Providing ongoing, confidential guidance to three leading international investment advisors regarding risks of antitrust enforcement and potential remedies in connection with multi-billion dollar transactions.
  • Representing Beth Israel Deaconess Medical Center, Atrius Health, Lahey Health, and Tufts University Medical Center in successfully blocking a nonprofit health organization's acquisition of South Shore Hospital Corporation and Hallmark Health. This was the first time a state court rejected a proposed antitrust settlement between the Massachusetts Attorney General's Office and private entities.
Professional Experience

Ms. Murino is a member of the District of Columbia Bar Association, the American Bar Association (ABA), and the American Health Lawyers Association (AHLA). She is active in the ABA’s Section of Antitrust Law, presently serving as an editor of Antitrust Magazine. She was previously chair of the Programs and Teleseminars Committee, where she helped oversee the planning of 8-9 conferences per year related to various antitrust topics. She served as vice chair of the 2014 Clayton Act at 100 Symposium, the 2013 Fall Forum, the 2013 Merger Retrospective Symposium, and the 2012 Presidential Transition Report Task Force. As a member of the AHLA, she has led webinars to educate lawyers on developments at the intersection of healthcare and antitrust law.

Ms. Murino routinely guest lectures on antitrust topics at American University's Washington College of Law, Boston University School of Law, the Columbus School of Law at Catholic University, George Washington University Law School, and the University of Michigan Law School. For eight years, she served as an adjunct professor of legal research and writing at George Washington University Law School. In addition to her professional associations, Ms. Murino has been involved in numerous community and philanthropic organizations, including serving as a Director on the Board of Trustees of StrongMinds Africa, a non-profit organization seeking to empower impoverished African women by treating depression through innovative group therapy programs. 

In The News









J.D., 2001
The George Washington University Law School

(With Honors)

B.A., 1998
American University, Economics and Political Science

(magna cum laude, Phi Beta Kappa, University Honors Program)



District of Columbia
New York


U.S. District Court for the District of Columbia
U.S. Supreme Court
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique